MedTrace Logo

Analysis on AEFI Surveillance Data for Live Attenuated Varicella Vaccine

NCT02983656 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 394

Last updated 2018-01-11

No results posted yet for this study

Summary

The purpose of this study is to observe the occurrence of adverse events of live attenuated varicella vaccine.

Conditions

  • Varicocele

Interventions

BIOLOGICAL

live attenuated varicella vaccine

Sponsors & Collaborators

  • Changchun Keygen Biological Products Co., Ltd.

    collaborator OTHER

  • Zhejiang Provincial Center for Disease Control and Prevention

    lead OTHER_GOV

Principal Investigators

  • Qian Li, Bachelor · Zhejiang Provincial Center for Disease Control and Prevention

Eligibility

Min Age
1 Year
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-08-31
Completion
2017-08-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02983656 on ClinicalTrials.gov